Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer

NCT00002919 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: cisplatin
DRUG: doxorubicin hydrochloride
DRUG: methotrexate
DRUG: vinblastine sulfate
PROCEDURE: conventional surgery

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]